Such other conditions may include hypertension, heart problems, chronic kidney disease and diabetes mellitus. There is a ...

Living with diabetes requires proactive lifestyle management. A balanced diet, regular exercise, and avoiding alcohol and ...

Fetch faculty members offer unique insights about behavior associated with diabetes, diabetic ketoacidosis, and new drug ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

The following is a summary of “Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

November is Diabetes awareness month. Diabetes (Diabetes mellitus) is a common endocrine disorder in all mammals, dogs and cats included. Diabetes is characterized by a dysfunction of insulin ...

Diabetes and obesity are intertwined health conditions with serious consequences if left unmanaged. Obesity increases the ...

Diabetes has plagued millions of people in the United States. Some of those people who are affected don’t know they have ...

Dr, Garner said, "Glucagon-like peptide-1 (GLP-1) receptor agonists represent a significant advancement in the treatment of ...